{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:41:14Z","timestamp":1789130474261,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.ymgme.2012.03.010","type":"journal-article","created":{"date-parts":[[2012,3,24]],"date-time":"2012-03-24T00:16:54Z","timestamp":1332548214000},"page":"135-141","source":"Crossref","is-referenced-by-count":93,"title":["Small fiber neuropathy in Fabry disease"],"prefix":"10.1016","volume":"106","author":[{"given":"Marieke","family":"Biegstraaten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla E.M.","family":"Hollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayienne","family":"Bakkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina G.","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes M.F.G.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo N.","family":"van Schaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2012.03.010_bb0005","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","article-title":"Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry","volume":"93","author":"Wilcox","year":"2008","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2012.03.010_bb0010","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur. J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.ymgme.2012.03.010_bb0015","first-page":"61","article-title":"Neuropathy and Fabry disease: pathogenesis and enzyme replacement therapy","volume":"106","author":"Schiffmann","year":"2006","journal-title":"Acta Neurol. Belg."},{"issue":"3","key":"10.1016\/j.ymgme.2012.03.010_bb0020","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.pain.2006.01.041","article-title":"Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values","volume":"123","author":"Rolke","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.ymgme.2012.03.010_bb0025","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1093\/brain\/awn093","article-title":"The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology","volume":"131","author":"Devigili","year":"2008","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ymgme.2012.03.010_bb0030","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/mus.20771","article-title":"Myelinated nerve endings in human skin","volume":"35","author":"Provitera","year":"2007","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.ymgme.2012.03.010_bb0035","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.cgh.2007.08.012","article-title":"Fabry Outcome Survey European Investigators. Gastrointestinal symptoms in 342 patients with Fabry disease: prevalence and response to enzyme replacement therapy","volume":"5","author":"Hoffmann","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.ymgme.2012.03.010_bb0040","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1681\/ASN.2006111263","article-title":"Weekly enzyme replacement therapy may slow decline of renal function in patients with Fabry disease who are on long-term biweekly dosing","volume":"18","author":"Schiffmann","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.ymgme.2012.03.010_bb0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/hrt.2006.104026","article-title":"Effects of enzyme replacement therapy on the cardiomyopathy of Anderson\u2013Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa","volume":"94","author":"Hughes","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.ymgme.2012.03.010_bb0050","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ymgme.2012.03.010_bb0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/mus.20550","article-title":"Enzyme replacement therapy and intraepidermal innervation density in Fabry disease","volume":"34","author":"Schiffmann","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2012.03.010_bb0060","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/mus.10497","article-title":"Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease","volume":"28","author":"Schiffmann","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2012.03.010_bb0065","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1212\/01.WNL.0000118207.84514.40","article-title":"Enzyme replacement therapy improves function of C-, Ad, and Ab-nerve fibers in Fabry neuropathy","volume":"62","author":"Hilz","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2012.03.010_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpain.2011.01.014","article-title":"The relation between small nerve fibre function, age, disease severity and pain in Fabry disease","author":"Biegstraaten","year":"2011","journal-title":"Eur. J. Pain"},{"issue":"6","key":"10.1016\/j.ymgme.2012.03.010_bb0075","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.clinph.2008.02.004","article-title":"Neuropathic symptoms and findings in women with Fabry disease","volume":"119","author":"Laaksonen","year":"2008","journal-title":"Clin. Neurophysiol."},{"issue":"6","key":"10.1016\/j.ymgme.2012.03.010_bb0080","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00004691-200212000-00011","article-title":"Small fiber dysfunction predominates in Fabry neuropathy","volume":"19","author":"D\u00fctsch","year":"2002","journal-title":"J. Clin. Neurophysiol."},{"issue":"5","key":"10.1016\/j.ymgme.2012.03.010_bb0085","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/mus.10236","article-title":"Physiological characterization of neuropathy in Fabry's disease","volume":"26","author":"Luciano","year":"2002","journal-title":"Muscle Nerve"},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2012.03.010_bb0090","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2009.06.032","article-title":"Functional and structural nerve fiber findings in heterozygote patients with Fabry disease","volume":"145","author":"Torvin M\u00f8ller","year":"2009","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.ymgme.2012.03.010_bb0095","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1526-4637.2008.00470.x","article-title":"Detection of a characteristic painful neuropathy in Fabry disease: a pilot study","volume":"9","author":"Maag","year":"2008","journal-title":"Pain Med."},{"issue":"2","key":"10.1016\/j.ymgme.2012.03.010_bb0100","first-page":"491","article-title":"The neurological complications of Anderson\u2013Fabry disease (alpha-galactosidase A deficiency)\u2014investigation of symptomatic and presymptomatic patients","volume":"75","author":"Morgan","year":"1990","journal-title":"Q. J. Med."},{"key":"10.1016\/j.ymgme.2012.03.010_bb0105","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1445-5994.2007.01366.x","article-title":"Neurology of Fabry disease","volume":"37","author":"Low","year":"2007","journal-title":"Intern. Med. J."},{"issue":"3","key":"10.1016\/j.ymgme.2012.03.010_bb0110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000115700","article-title":"Pathological study of the sural nerve in Fabry's disease","volume":"23","author":"Gemignani","year":"1984","journal-title":"Eur. Neurol."},{"issue":"2","key":"10.1016\/j.ymgme.2012.03.010_bb0115","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1001\/archneur.1974.00490380068009","article-title":"Loss of small peripheral sensory neurons in Fabry disease. Histologic and morphometric evaluation of cutaneous nerves, spinal ganglia, and posterior columns","volume":"31","author":"Onishi","year":"1974","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.ymgme.2012.03.010_bb0120","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1212\/WNL.52.6.1249","article-title":"Quantitative analysis of epidermal innervation in Fabry disease","volume":"52","author":"Scott","year":"1999","journal-title":"Neurology"},{"issue":"406","key":"10.1016\/j.ymgme.2012.03.010_bb0125","first-page":"412","article-title":"Small fibre neuropathy in female patients with Fabry disease","volume":"41","author":"Liguori","year":"2010","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.ymgme.2012.03.010_bb0130","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.ymgme.2012.03.010_bb0135","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bbadis.2010.05.003","article-title":"Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry disease","volume":"1802","author":"Rombach","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.ymgme.2012.03.010_bb0140","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ymgme.2012.03.010_bb0145","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1111\/j.1651-2227.2002.tb03110.x","article-title":"Pathophysiology and assessment of neuropathic pain in Fabry disease","volume":"439","author":"Schiffmann","year":"2002","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2012.03.010_bb0150","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.1468-1331.2010.02969.x","article-title":"EFNS guidelines on neuropathic pain assessment: revised 2009","volume":"17","author":"Cruccu","year":"2010","journal-title":"Eur. J. Neurol."},{"issue":"11","key":"10.1016\/j.ymgme.2012.03.010_bb0155","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson\u2013Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males","volume":"38","author":"MacDermot","year":"2001","journal-title":"J. Med. Genet."},{"issue":"5","key":"10.1016\/j.ymgme.2012.03.010_bb0160","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.32.5.498","article-title":"Fabry disease: impaired autonomic function","volume":"32","author":"Cable","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2012.03.010_bb0165","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1651-2227.2002.tb03108.x","article-title":"Evaluation of peripheral and autonomic nerve function in Fabry disease","volume":"439","author":"Hilz","year":"2002","journal-title":"Acta Paediatr. Suppl."},{"key":"10.1016\/j.ymgme.2012.03.010_bb0170","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1097\/01.ASN.0000015239.57436.18","article-title":"Anderson\u2013Fabry disease: extrarenal, neurological manifestations","volume":"13","author":"Kolodny","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.ymgme.2012.03.010_bb0175","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/0002-8703(83)90241-7","article-title":"Peripheral hemodynamics in patients with Fabry's disease","volume":"105","author":"Seino","year":"1983","journal-title":"Am. Heart J."},{"issue":"2","key":"10.1016\/j.ymgme.2012.03.010_bb0180","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1085-9489.2006.00076.x","article-title":"Small-fibre neuropathy in female Fabry patients: reduced allodynia and skin blood flow after topical capsaicin","volume":"11","author":"Torvin M\u00f8ller","year":"2006","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"5","key":"10.1016\/j.ymgme.2012.03.010_bb0185","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s00415-004-0364-9","article-title":"Reduced cerebral blood flow velocity and impaired cerebral autoregulation in patients with Fabry disease","volume":"251","author":"Hilz","year":"2004","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.ymgme.2012.03.010_bb0190","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1651-2227.2008.00700.x","article-title":"Cardiac manifestations of Anderson\u2013Fabry disease in children and adolescents","volume":"97","author":"Kampmann","year":"2008","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2012.03.010_bb0195","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1542\/peds.2005-2895","article-title":"Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease","volume":"118","author":"Ries","year":"2006","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.ymgme.2012.03.010_bb0200","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1161\/01.STR.32.7.1559","article-title":"Enhanced endothelium-dependent vasodilation in Fabry disease","volume":"32","author":"Altarescu","year":"2001","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.ymgme.2012.03.010_bb0205","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-510X(95)00355-6","article-title":"Autonomic neuropathy, I. Clinical features, investigation, pathophysiology, and treatment","volume":"137","author":"McDougall","year":"1996","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.ymgme.2012.03.010_bb0210","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/brain\/110.3.563","article-title":"Hereditary sensory neuropathy with neurotrophic keratitis. Description of an autosomal recessive disorder with a selective reduction of small myelinated nerve fibres and a discussion of the classification of the hereditary sensory neuropathies","volume":"110","author":"Donaghy","year":"1987","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2012.03.010_bb0215","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M109.092973","article-title":"Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids","author":"Penno","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.03.010_bb0220","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-1172-3-7","article-title":"Hereditary sensory neuropathy type I","volume":"3","author":"Auer-Grumbach","year":"2008","journal-title":"Orphanet J. Rare Dis."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719212001114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719212001114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T01:15:41Z","timestamp":1561511741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719212001114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1096719212001114"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2012.03.010","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}